Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Annovis Bio, Inc. (ANVS) had Current Liabilities of $2.81M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.22M |
|
-- |
|
-- |
|
$6.27M |
|
$-6.27M |
|
$0.05M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.27M |
|
$-6.27M |
|
19.49M |
|
19.49M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$21.45M |
|
-- |
|
-- |
|
$21.45M |
|
|
Current Liabilities |
$2.81M |
-- |
|
$0.32M |
|
$3.12M |
|
$18.33M |
|
$18.33M |
|
$18.33M |
|
19.49M |
|
| Cash Flow Statement Financials | |
$-13.21M |
|
-- |
|
$19.78M |
|
$10.55M |
|
$17.13M |
|
$6.58M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.93% |
|
-33.93% |
|
-28.99% |
|
-33.93% |
|
$0.94 |
|
$-0.68 |
|
$-0.68 |
|